AIM at Melanoma Announces the Launch of AIM at Skin Cancer
New Website Dedicated to Providing Individuals with Vital Knowledge and Tools to Protect Their Skin and Lead Healthy Lives CONTACT:…
01/25/2024
AIM at Melanoma Announces the Launch of AIM at Skin Cancer
New Website Dedicated to Providing Individuals with Vital Knowledge and Tools to Protect Their Skin and Lead Healthy Lives CONTACT:…
01/18/2024
FDA Approves First AI-Powered Skin Cancer Diagnostic Tool
FDA Approves First AI-Powered Skin Cancer Diagnostic Tool The DermaSensor device demonstrates a high rate of sensitivity in the detection…
|
|
01/11/2024
AIM at Melanoma Celebrating 20 Year Anniversary
Twenty years ago, the AIM at Melanoma Foundation was established by a determined woman with a relentless drive to find…
01/09/2024
Vitality Should be on the Table for All Cancer Survivors
Join us as we dive deep into the emotional path of survivorship. Dr. Liu sat down with Samantha Siegel, MD,…
|
01/02/2024
Clinical Trials Saved My Life
By Mara Klecker When Barbara Hunter found out her melanoma had returned as Stage IV and was in her liver,…
|
12/19/2023
Navigating Melanoma During the Holidays
The holiday season is often portrayed as a time of joy, love, and celebration. However, for melanoma cancer patients, it…
|
12/18/2023
The Clinical Trial Experience: A Patient’s Perspective
In 2010, Mary Elizabeth Williams was diagnosed with metastatic melanoma. The following year, she was offered the opportunity to participate…
|
12/05/2023
Celebrate Survivorship – Give Towards Melanoma Research
Melanoma knows no boundaries. It’s a disease that affects people of all ages, races, and backgrounds. And it’s a devastating…
|
11/14/2023
Melanoma Cancer and Financial Toxicity
While being diagnosed with cancer alone can put a person under tremendous amounts of mental and emotional stress, the additional…
|
10/31/2023
National Family Caregiver Month
National Caregiver Month is observed every November to honor and appreciate the selfless individuals who dedicate their lives to caring…
|
Recent Posts
May. 28, 2025
Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications
May. 14, 2025
Parenting Through Cancer
May. 09, 2025
Tri-State Melanoma Consortium – Inaugural Convening
May. 01, 2025
AIM at Melanoma + WEARSPF®: Partnering for a Cause This Melanoma Awareness Month
May. 01, 2025